ANDA 217410, held by Ajanta Pharma Ltd. Fluphenazine Hydrochloride.
As of Nov 16, 2026, ANDA 217410 (Fluphenazine Hydrochloride), held by Ajanta Pharma Ltd, was first approved by FDA on Jan 5, 2023, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 5, 2023 | Original application | Approved | None posted |
| Fluphenazine Hydrochloride1MG · tablet;oral | Fluphenazine Hydrochloride | Rx |
| Fluphenazine Hydrochloride2.5MG · tablet;oral | Fluphenazine Hydrochloride | Rx |
| Fluphenazine Hydrochloride5MG · tablet;oral | Fluphenazine Hydrochloride | Rx |
| Fluphenazine Hydrochloride10MG · tablet;oral | Fluphenazine Hydrochloride | Rx |
| Jan 22, 2025 | Supplement 1Labeling · Standard review | Approved | None posted |
| Jan 5, 2023 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters